Dashboard
Manage Tickers

JANXJanux Therapeutics, Inc.

Nasdaq januxrx.com


$ 51.99 $ -3.43 (-6.19 %)    

Thursday, 09-May-2024 15:59:58 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.33 $ 0.96 (0.22 %)
DIA $ 394.43 $ 3.52 (0.9 %)
SPY $ 520.56 $ 2.98 (0.58 %)
TLT $ 90.69 $ 0.44 (0.49 %)
GLD $ 216.93 $ 3.37 (1.58 %)
$ 51.94
$ 54.27
$ 0.00 x 0
$ 0.00 x 0
$ 50.94 - $ 54.27
$ 5.65 - $ 65.60
1,492,791
na
2.55B
$ 2.13
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-08-2023 06-30-2023 10-Q
5 05-09-2023 03-31-2023 10-Q
6 03-10-2023 12-31-2022 10-K
7 11-10-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 03-18-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-janux-therapeutics-maintains-100-price-target
Cantor Fitzgerald Reiterates Overweight on...
05/09/2024 14:20:09

Cantor Fitzgerald analyst Josh Schimmer reiterates Janux Therapeutics (NASDAQ:JANX) with a Overweight and maintains $100 pri...

wedbush-maintains-outperform-on-janux-therapeutics-raises-price-target-to-74
Wedbush Maintains Outperform on Janux Ther...
05/08/2024 14:43:28

Wedbush analyst Robert Driscoll maintains Janux Therapeutics (NASDAQ:JANX) with a Outperform and raises the price target fro...

janux-therapeutics-inc-files-for-mixed-shelf-sales-agreement-prospectus-covers-offering-of-up-to-150m-of-common-stock-that-may-be-issued-and-sold-from-time-to-time
Janux Therapeutics Inc Files For Mixed She...
05/08/2024 13:16:44

- Sec Filing

janux-therapeutics-q1-eps-030-beats-033-estimate-sales-125m-beat-76000k-estimate
Janux Therapeutics Q1 EPS $(0.30) Beats $(...
05/07/2024 20:49:09

Janux Therapeutics (NASDAQ:JANX) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(...

a-glimpse-into-the-expert-outlook-on-janux-therapeutics-through-6-analysts
A Glimpse Into The Expert Outlook On Janux...
04/16/2024 12:00:53

jonestrading-initiates-coverage-on-janux-therapeutics-with-buy-rating-announces-price-target-of-70
JonesTrading Initiates Coverage On Janux T...
04/16/2024 10:50:27

JonesTrading analyst Soumit Roy initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price...

why-fastenal-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Fastenal Shares Are Trading Lower By A...
04/11/2024 17:33:07

Shares of Fastenal Company (NASDAQ: FAST) fell sharply during Thursday’s session following worse-than-expected first-quarter f...

why-is-cancer-focused-janux-therapeutics-stock-trading-higher-on-thursday
Why Is Cancer-Focused Janux Therapeutics S...
04/11/2024 16:13:56

Janux Therapeutics may be up for sale amid interest from major pharmaceutical firms. With shares quadrupling this year and a su...

enliven-therapeutics-alpine-immune-sciences-janux-therapeutics-and-other-big-stocks-moving-higher-on-thursday
Enliven Therapeutics, Alpine Immune Scienc...
04/11/2024 14:01:51

U.S. stocks were mixed, with the Dow Jones index falling over 50 points on Thursday. Shares of Enliven Therapeutics, Inc. (NA...

janux-therapeutics-shares-resume-trade-following-circuit-breaker-halt-stock-now-up-18
Janux Therapeutics Shares Resume Trade Fol...
04/10/2024 17:48:38

drugmaker-janux-therapeutics-said-to-weigh-possible-sale
"Drugmaker Janux Therapeutics Said To Weig...
04/10/2024 17:43:08

- Bloomberg

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
04/04/2024 17:35:24

btig-initiates-coverage-on-janux-therapeutics-with-buy-rating-announces-price-target-of-62
BTIG Initiates Coverage On Janux Therapeut...
03/21/2024 10:00:23

BTIG analyst Kaveri Pohlman initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Buy rating and announces Price Tar...

cancer-focused-janux-therapeutics-platform-has-tremendous-opportunity-analyst
Cancer-Focused Janux Therapeutics Platform...
03/20/2024 17:44:16

Cantor Fitzgerald's coverage on Janux Therapeutics and its TRACTr/TRACir platform targeting diverse tumor antigens and canc...

forecasting-the-future-4-analyst-projections-for-janux-therapeutics
Forecasting The Future: 4 Analyst Projecti...
03/20/2024 14:00:54

cantor-fitzgerald-initiates-coverage-on-janux-therapeutics-with-overweight-rating-announces-price-target-of-100
Cantor Fitzgerald Initiates Coverage On Ja...
03/20/2024 09:24:21

Cantor Fitzgerald analyst Josh Schimmer initiates coverage on Janux Therapeutics (NASDAQ:JANX) with a Overweight rating and ...

b-of-a-securities-maintains-buy-rating-for-janux-therapeutics-heres-what-you-need-to-know
B of A Securities Maintains Buy Rating for...
03/13/2024 17:00:15

b-of-a-securities-maintains-buy-on-janux-therapeutics-raises-price-target-to-48
B of A Securities Maintains Buy on Janux T...
03/13/2024 14:31:15

B of A Securities analyst Geoff Meacham maintains Janux Therapeutics (NASDAQ:JANX) with a Buy and raises the price target fr...

why-asana-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Asana Shares Are Trading Lower By 11%?...
03/12/2024 18:07:31

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

hc-wainwright--co-maintains-buy-on-janux-therapeutics-raises-price-target-to-50
HC Wainwright & Co. Maintains Buy on Janux...
03/11/2024 10:38:11

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Janux Therapeutics (NASDAQ:JANX) with a Buy and raises the ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION